Vimarsana
Biggest News Aggregation in the World

Page 11 - Nasdaq Coll News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Nasdaq Coll. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Nasdaq Coll Today - Breaking & Trending Today

Collegium Pharmaceutical, Inc. (NASDAQ:COLL) Expected to Announce Quarterly Sales of $78.95 Million - Vimarsana News

Collegium Pharmaceutical, Inc. (NASDAQ:COLL) Expected to Announce Quarterly Sales of $78.95 Million

Equities research analysts forecast that Collegium Pharmaceutical, Inc. (NASDAQ:COLL – Get Rating) will post sales of $78.95 million for the current fiscal quarter, Zacks Investment Research reports. Four analysts have issued estimates for Collegium Pharmaceutical’s earnings. The lowest sales estimate is $75.10 million and the highest is $83.27 million. Collegium Pharmaceutical posted sales of $87.72 […]

$0.97 Earnings Per Share Expected for Collegium Pharmaceutical, Inc. (NASDAQ:COLL) This Quarter - Vimarsana News

$0.97 Earnings Per Share Expected for Collegium Pharmaceutical, Inc. (NASDAQ:COLL) This Quarter

Brokerages expect Collegium Pharmaceutical, Inc. (NASDAQ:COLL – Get Rating) to announce $0.97 earnings per share for the current fiscal quarter, Zacks reports. Four analysts have provided estimates for Collegium Pharmaceutical’s earnings, with estimates ranging from $0.82 to $1.03. Collegium Pharmaceutical posted earnings of $0.41 per share in the same quarter last year, which would suggest […]

$78.95 Million in Sales Expected for Collegium Pharmaceutical, Inc. (NASDAQ:COLL) This Quarter - Vimarsana News

$78.95 Million in Sales Expected for Collegium Pharmaceutical, Inc. (NASDAQ:COLL) This Quarter

Wall Street brokerages expect that Collegium Pharmaceutical, Inc. (NASDAQ:COLL – Get Rating) will report $78.95 million in sales for the current quarter, Zacks Investment Research reports. Four analysts have made estimates for Collegium Pharmaceutical’s earnings, with estimates ranging from $75.10 million to $83.27 million. Collegium Pharmaceutical reported sales of $87.72 million during the same quarter […]

Zacks: Brokerages Anticipate Collegium Pharmaceutical, Inc. (NASDAQ:COLL) to Post $0.99 EPS - Vimarsana News

Zacks: Brokerages Anticipate Collegium Pharmaceutical, Inc. (NASDAQ:COLL) to Post $0.99 EPS

Wall Street brokerages expect Collegium Pharmaceutical, Inc. (NASDAQ:COLL – Get Rating) to post earnings of $0.99 per share for the current quarter, according to Zacks. Four analysts have issued estimates for Collegium Pharmaceutical’s earnings, with the lowest EPS estimate coming in at $0.87 and the highest estimate coming in at $1.03. Collegium Pharmaceutical reported earnings […]

Collegium Pharmaceutical (NASDAQ:COLL) Cut to C+ at TheStreet - Vimarsana News

Collegium Pharmaceutical (NASDAQ:COLL) Cut to C+ at TheStreet

Collegium Pharmaceutical (NASDAQ:COLL – Get Rating) was downgraded by stock analysts at TheStreet from a “b-” rating to a “c+” rating in a research note issued on Monday, TheStreetRatingsTable reports. Several other research firms have also recently commented on COLL. HC Wainwright boosted their target price on Collegium Pharmaceutical from $26.00 to $29.00 and gave […]